This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a ceiling value of $1,622.97 and a performance period through July 2, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract, valued at $2,757.78, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of June 12, 2024. The award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military...
This federal contract award, valued at $1,082.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of TOBRADEX eye ointment to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. The contract award, valued at $3,826.33, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award, valued at $1,323.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. This is a delivery order contract with a firm-fixed price pricing type, with an ultimate completion date of November 6, 2023. The contract does not have a set-aside designation, indicating open...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY6HS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.51 firm fixed-price delivery order is for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a prescription medication. The contract has a ceiling value of $10,524.72 and is a firm fixed-price contract. The period of performance extends until June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX Eye Ointment 3.5GM. The $3,547.88 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will deliver these medical supplies to support federal healthcare providers and programs. This delivery order is part of a larger...